SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001596770-15-000021
Filing Date
2015-02-12
Accepted
2015-02-12 16:12:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SUNESIS SCHEDULE 13G - 2-11-15 schedule13g.htm SC 13G 181216
  Complete submission text file 0001596770-15-000021.txt   182870
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 15606301
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ALTA BIOPHARMA PARTNERS III LP (Filed by) CIK: 0001257444 (see all company filings)

IRS No.: 050573803 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G